Ellis Andrea bought BBIO
July 9, 2026 · Form 4 insider transaction
Ellis Andrea bought 17,167 shares of BridgeBio Pharma, Inc. at $16.75 per share, a transaction worth $287.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,167
Price
$16.75
Total value
$287.5K
InsiderEllis Andrea
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2026
Filing dateJuly 13, 2026
Shares owned after39,746
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.